ULURU Inc (ULUR)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
NON-OPERATING ESTABLISHMENTS
CEO:
Employees:
2
4452 BELTWAY DRIVE, ADDISON, TX 75001
214-905-5145

ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.

Data derived from most recent annual or quarterly report
Market Cap 30.264 Million Shares Outstanding30.57 Million Avg 30-day Volume 49.257 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue26.5519 Debt to Equity0.193 EBITDA-862.406 Thousand
Price to Book Value3.4821 Operating Margin-316.9428 Enterprise Value13.125 Million
Current Ratio1.468 EPS Growth0 Quick Ratio1.238
1 Yr BETA -19.3148 52-week High/Low 0.0 / Profit Margin-387.2584
Operating Cash Flow Growth-22.8921 Altman Z-Score-9.9556 Free Cash Flow to Firm -1.371 Million
View SEC Filings from ULUR instead.

View recent insider trading info

Funds Holding ULUR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ULUR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-02-05:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-12-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-04-26:
    Item 4.01: Changes in Registrant's Certifying Accountant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-12-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-07-27:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-04-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-03-01:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-01-06:
    Item 4.01: Changes in Registrant's Certifying Accountant
  • 8-K: filed on 2016-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-09-30:
    Item 4.01: Changes in Registrant's Certifying Accountant
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TIEDT OKSANA

    • Director
    0 2017-03-31 0

    SHAH ANISH VITHALDAS

    • Director
    0 2017-03-31 0

    BOSE ARINDAM

    • Director
    0 2017-03-31 0

    VELOCITAS I LLC

    • 10% Owner
    0 2017-03-31 0

    VELOCITAS PARTNERS LLC

    • 10% Owner
    196,430,057 2017-03-31 0

    SACKS MICHAEL IVAN

    • 10% Owner
    • SEE EXPLANATION BELOW
    0 2017-03-01 0

    SACKS BRADLEY J.

    CENTRIC CAPITAL VENTURES LLC

    • Director
    • SEE EXPLANATION ABOVESEE EXPLANATION ABOVE
    0 2017-03-01 0

    SHAH VAIDEHI CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2017-02-27 0

    WALLBERG TERRANCE K CHIEF FINANCIAL OFFICER

    • Officer
    • Director
    1,735,449 2016-03-29 0

    IPMD GMBH

    • 10% Owner
    10,204,365 2015-12-24 0

    GOLDRICH ROBERT F

    • Director
    0 2015-09-25 0

    SACKS BRADLEY J.

    • Director
    2,000,000 2015-07-29 0

    GRAY KERRY P CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    • 10% Owner
    1,599,919 2014-09-25 0

    JEFFREY B DAVIS

    • Director
    0 2014-09-25 0

    KERSCHBAUMER HELMUT

    • Director
    5,000,000 2014-09-25 0

    KUEHNE KLAUS

    • Director
    5,000,000 2014-09-25 0

    PUNCH TRUST

    • SEE FOOTNOTE (1)
    1,000,000 2014-01-31 0

    STONE JEFFREY A

    • Director
    0 2013-03-20 0

    VAN DEN HOOFF RENAAT PRESIDENT & CEO

    • Officer
    210,494 2010-06-04 0

    CROUSE WILLIAM W

    • Director
    50,000 2010-04-26 0

    OSS CAPITAL MANAGEMENT

    SCHAFER BROTHER LLC

    SCHAFER OSCAR

    • 10% Owner
    No longer subject to file 2010-04-01 0

    JANA PARTNERS LLC

    • 10% Owner
    No longer subject to file 2009-05-13 0

    BRENCOURT ADVISORS LLC

    • 10% Owner
    10,556,589 2008-10-28 0

    AHRENS RONALD A

    • Director
    0 2008-06-19 0

    VERNON W ANTHONY

    • Director
    0 2008-05-15 0

    REESE DAVID EMERY

    • Director
    1,580 2007-11-19 0

    OSS CAPITAL MANAGEMENT

    • 10% Owner
    11,687,415 2007-11-13 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ULURU INC ULUR 2023-05-03 22:15:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 21:45:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 21:15:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 20:45:03 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 20:15:05 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 19:45:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 19:15:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 18:45:03 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 18:15:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 17:45:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 17:15:04 UTC 4.52 0.3 10000
    ULURU INC ULUR 2023-05-03 16:45:04 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 16:15:04 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 15:45:03 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 15:15:04 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 14:45:03 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 14:15:04 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 13:45:04 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 13:15:03 UTC 4.51 0.3 10000
    ULURU INC ULUR 2023-05-03 12:45:03 UTC 4.51 0.3 10000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments